Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Reduce the Number of Out-of-Network Patient Referrals with a Robust EHR

Patient referrals are an important part of helping patients find the specialists they need. However, it’s not always easy to find in-network referrals. The referral process can be complicated without the right tools. If you have a robust EHR (electronic health record) system that includes internal provider information and a directory, you can easily find…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Patient referrals are an important part of helping patients find the specialists they need. However, it’s not always easy to find in-network referrals. The referral process can be complicated without the right tools. If you have a robust EHR (electronic health record) system that includes internal provider information and a directory, you can easily find providers within your network to refer patients. When patients stay in-network, they have easier access to nearby doctors, communication, appointment scheduling and more.

Providers Struggle with In-Network Referrals

Physicians and providers understand the importance of in-network referrals. They know it improves care coordination and helps retain patients. However, a survey by Kyruus revealed that 79 percent of physicians still refer patients to providers outside their network.[1]

There are lots of reasons for this high number, but much of it is tied to a lack of data and information like schedules and specialties. When providers have access to this kind of data, the referral process goes much smoother both internally and for the patient. Ultimately, you want your patients to get the best care and make it convenient for the patient. The right EHR empowers you to do both.

In-Network Referrals Bring Convenience to Patients

In-network referrals are more likely to be close by or local to the patient, meaning they don’t have to venture far outside their community for care. Inability getting to providers for care can be a significant issue, so making this easier for patients is key.

If a provider refers a patient out of their network, they risk having to pay more seeing as most insurance companies will cover less of the payment for going out of network. Staying in-network keeps costs down for patients. Special cases may require patients to go out of network, however, it is in the patient’s best interest to give them the care they need at a cost they can afford.

In-Network Referrals Make Things Easier for Doctors

The most important aspect of in-network referrals is the ability to deliver patient-centered coordinated care. When providers are in the same network, they can converse easier about the patient’s care plan and share information more readily, often through the EHR system.

When all the patient’s data is in one place and all providers are on the same page, the patient gets the correct treatments or medications, and all providers stay in the know about his or her progress.

How a Robust EHR Enables More In-Network Referrals

All EHR’s are not the same. Some have limited access to data that would determine a provider’s network status. When they don’t have the data available in the EHR, the provider must do their own research or use another external resource. Without the proper data and information, providers may make referrals not in the best interest of the patient. According to the Kyruus survey, providers lamented they did not have access to essential data about other providers with only 63 percent saying they had information about the specialty or subspecialty.1

In addition to a lack of clinical data, 57 percent of physicians said they had little access to scheduling information. 1 Because they have all around limited information, physicians are more likely to refer to the same provider, which leads to poor network usage and can cause challenges with scheduling, and patients may have to wait longer to see the specialist. Physicians could overcome these challenges with an EHR that delivered easy access to the information.

Patient referrals generate revenue for networks. Yet, the referral system for many networks is outdated and doesn’t take advantage of the EHR, which can be a powerful tool. When patients go out of network, coordination of care suffers, patients have a poor experience, and systems lose revenue. The solution is a better EHR.

ChartLogic’s EHR Makes Things Simpler

Thousands of providers use ChartLogic’s EHR every day because it gives them the functionality and flexibility they need. Known as the first meaningful use certified EHR in the industry, it offers a customizable template builder, a Patient Portal, ePrescribing, data share capabilities, labs, and referral replies amongst other efficiencies. Learn more about the ChartLogic’s EHR today.

[1] https://www.kyruus.com/2018-referral-trends-report

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512